Literature DB >> 25986378

Advanced glycation end products facilitate bacterial adherence in urinary tract infection in diabetic mice.

Ahmet Ozer1, Cengiz Z Altuntas2, Kenan Izgi3, Fuat Bicer3, Scott J Hultgren4, Guiming Liu2, Firouz Daneshgari5.   

Abstract

Diabetic individuals have increased susceptibility to urinary tract infection (UTI), a common, painful condition. During diabetes mellitus, non-enzymatic reactions between reducing sugars and protein amine groups result in excessive production of advanced glycation end products (AGEs) that accumulate in tissues. Since bacteria adhere to cell surfaces by binding to carbohydrates, we hypothesized that adherence of bacteria to the bladder in diabetics may be enhanced by accumulation of AGEs on urothelial surface proteins. Using a murine model of UTI, we observed increased adherence of type 1 fimbriated uropathogenic Escherichia coli (UPEC) to the bladder in streptozotocin-induced diabetic female mice compared with age-matched controls, along with increased concentrations of two common AGEs in superficial urothelial cells from diabetic bladders. Several lectins with different specificities exhibited increased binding to urothelial homogenates from diabetic mice compared with controls, and two of those lectins also bound to AGEs. Furthermore, mannose-binding type 1 fimbriae isolated from UPEC bound to different AGEs, and UPEC adherence to the bladder in diabetic mice, were inhibited by pretreatment of mice with the AGE inhibitor pyridoxamine. These results strongly suggest a role for urothelial AGE accumulation in increased bacterial adherence during UTI in diabetes. © FEMS 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Nε-(carboxyethyl)lysine; Nε-(carboxymethyl) lysine; enzyme-linked lectin assay; glycoprotein; lectin

Mesh:

Substances:

Year:  2014        PMID: 25986378      PMCID: PMC4444075          DOI: 10.1093/femspd/ftu004

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  53 in total

1.  Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.

Authors:  Mitsuo Tanimoto; Tomohito Gohda; Shigeru Kaneko; Shinji Hagiwara; Maki Murakoshi; Tatsuya Aoki; Kaori Yamada; Takamichi Ito; Masakazu Matsumoto; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

2.  Rat urothelium: improved techniques for serial cultivation, expansion, freezing and reconstitution onto acellular matrix.

Authors:  Eric A Kurzrock; Deborah K Lieu; Lea A deGraffenried; Roslyn R Isseroff
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

Review 3.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

4.  Age-associated changes in glycosylation of CD43 and CD45 on mouse CD4 T cells.

Authors:  Gonzalo G Garcia; Scott B Berger; Amir A Sadighi Akha; Richard A Miller
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

5.  Estimating health care-associated infections and deaths in U.S. hospitals, 2002.

Authors:  R Monina Klevens; Jonathan R Edwards; Chesley L Richards; Teresa C Horan; Robert P Gaynes; Daniel A Pollock; Denise M Cardo
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

Review 6.  Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models.

Authors:  Swaine L Chen; Sara L Jackson; Edward J Boyko
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

7.  Immunohistochemical detection of advanced glycation end products in human bladder with specific monoclonal antibody.

Authors:  Kenshi Matsumoto; Yukio Fujiwara; Ryoji Nagai; Masaki Yoshida
Journal:  Int J Urol       Date:  2009-04       Impact factor: 3.369

Review 8.  Uroplakins in urothelial biology, function, and disease.

Authors:  Xue-Ru Wu; Xiang-Peng Kong; Angel Pellicer; Gert Kreibich; Tung-Tien Sun
Journal:  Kidney Int       Date:  2009-04-01       Impact factor: 10.612

9.  Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis.

Authors:  Zhengshan Zhao; Chunying Zhao; Xu Hannah Zhang; Feng Zheng; Weijing Cai; Helen Vlassara; Zhongmin Alex Ma
Journal:  Endocrinology       Date:  2009-02-26       Impact factor: 4.736

10.  Bacteria-induced uroplakin signaling mediates bladder response to infection.

Authors:  Praveen Thumbikat; Ruth E Berry; Ge Zhou; Benjamin K Billips; Ryan E Yaggie; Tetiana Zaichuk; Tung-Tien Sun; Anthony J Schaeffer; David J Klumpp
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more
  7 in total

1.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2019-10-31       Impact factor: 9.941

Review 2.  Systematic Review of Literature Examining Bacterial Urinary Tract Infections in Diabetes.

Authors:  Santosh Paudel; Preeti P John; Seyedeh Leila Poorbaghi; Tara M Randis; Ritwij Kulkarni
Journal:  J Diabetes Res       Date:  2022-05-17       Impact factor: 4.061

3.  Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Authors:  Matt S Conover; Ségolène Ruer; Joemar Taganna; Vasilios Kalas; Henri De Greve; Jerome S Pinkner; Karen W Dodson; Han Remaut; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2016-09-22       Impact factor: 21.023

4.  Glycosuria Alters Uropathogenic Escherichia coli Global Gene Expression and Virulence.

Authors:  Md Jahirul Islam; Kamal Bagale; Preeti P John; Zachary Kurtz; Ritwij Kulkarni
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

5.  Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection.

Authors:  Kathryn A Patras; Alison Coady; Priyanka Babu; Samuel R Shing; Albert D Ha; Emma Rooholfada; Stephanie L Brandt; Matthew Geriak; Richard L Gallo; Victor Nizet
Journal:  mSphere       Date:  2020-04-22       Impact factor: 4.389

6.  Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder.

Authors:  Soumitra Mohanty; Witchuda Kamolvit; Andrea Scheffschick; Anneli Björklund; Jonas Tovi; Alexander Espinosa; Kerstin Brismar; Thomas Nyström; Jens M Schröder; Claes-Göran Östenson; Pontus Aspenström; Hanna Brauner; Annelie Brauner
Journal:  Nat Commun       Date:  2022-09-20       Impact factor: 17.694

7.  Repurposing pyridoxamine for therapeutic intervention of intravascular cell-cell interactions in mouse models of sickle cell disease.

Authors:  Jing Li; Si-Yeon Jeong; Bei Xiong; Alan Tseng; Andrew B Mahon; Steven Isaacman; Victor R Gordeuk; Jaehyung Cho
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.